Dow futures gain over 200 points on Monday: 5 things to know before Wall Street opens

US equity futures, including the Dow, Nasdaq, and S&P 500, rallied significantly on Monday, driven by growing optimism as the Senate advanced a bipartisan bill to end the prolonged government shutdown. This positive market sentiment was further bolstered by China's decision to temporarily suspend export controls on critical rare earth elements and minerals until November 2026, easing trade tensions and benefiting sectors like semiconductors. In corporate news, Pfizer completed a $10 billion acquisition of obesity drug developer Metsera, outbidding Novo Nordisk, while gold prices climbed over 1% on expectations of a December Fed rate cut amidst weak US economic data, contributing to a broader global market rally.

Analysis

US equity futures rallied significantly, with Dow futures climbing over 200 points and Nasdaq futures rising over 375 points, as the Senate advanced a bipartisan bill to end the government shutdown by January 30, 2026. This positive sentiment was bolstered by China's temporary suspension of rare earth export controls until November 2026, easing trade tensions and benefiting technology and semiconductor sectors. The resolution of political uncertainty spurred a broad global market rally, with Kospi jumping 3% and the DAX gaining approximately 1.3%.

Pfizer secured a substantial $10 billion acquisition of Metsera, an obesity drug developer, outbidding Novo Nordisk with an offer valuing Metsera at $86.25 per share. This strategic move, backed by Metsera's board due to fewer regulatory hurdles, signals Pfizer's aggressive expansion into the high-growth obesity drug market and highlights intense competition for innovative therapeutic assets.

Despite broad market optimism, gold prices surged over 1% on November 10, 2025, reaching $4,053.40 an ounce for spot gold, driven by increasing expectations of a December Federal Reserve interest rate cut. This rally in the safe-haven asset was underpinned by concerns over a slowing global economy and weak US economic data, including job losses and declining consumer confidence, suggesting underlying economic fragility persists.

Key Decisions for Investors

• Investors should monitor the effective implementation of the government shutdown resolution and the durability of China's rare earth export policy pause for sustained market stability.
• Evaluate opportunities in technology and semiconductor sectors due to eased trade tensions, and assess pharmaceutical companies for strategic M&A in high-growth therapeutic areas like obesity drugs.
• Consider hedging strategies, potentially including exposure to safe-haven assets like gold, given the persistent concerns about global economic slowdown and potential Fed rate cuts despite the immediate market rally.